Results 21 to 30 of about 17,377 (218)
Cardiac microcalcifications in transthyretin (ATTR) amyloidosis [PDF]
International Journal of Cardiology, 2022 Bone tracers bind to amyloid-containing heart of most patients with ATTR amyloidosis. Amyloid deposits outside the heart are often scarce and bone scintigraphy is increasingly often used to diagnose cardiac involvement. However, the nature of the binding of bone tracers to the heart is not clear.To identify possible calcium deposits in hearts with ...
Ulrika, Thelander +6 more
openaire +2 more sources
The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective [PDF]
, 2023 Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed disease associated with high mortality rates and the patient journey is characterized by increased complexities.
Efstratios A. Apostolou +11 more
core +3 more sources
ATTR- and AFib amyloid - two different types of amyloid in the annular ligament of trigger finger
, 2023 Histological examination of tissue specimens obtained during surgical treatment of trigger finger frequently encountered unclassifiable amyloid deposits in the annular ligament.
Hans-Detlef Axmann (11845617) +11 more
core +1 more source
Scientific Reports, 2022 To determine the differences in left atrial (LA) function and geometry assessed by cardiac magnetic resonance (CMR) between transthyretin (ATTR) and immunoglobulin light chain (AL) cardiac amyloidosis (CA).
Cassady Palmer +6 more
doaj +1 more source
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
Open Heart, 2021 Objective Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive and fatal condition caused by deposition of transthyretin amyloid fibrils in the heart.
J Gustav Smith +9 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is commonly diagnosed in older adults, in particular the wild-type (ATTRwt), which is regarded as an age-related disease.
Biobelemoye Irabor +4 more
doaj +1 more source
ESC Heart Failure, 2023 While patients with transthyretin cardiac amyloidosis (ATTR‐CA) typically present with concentric or asymmetric hypertrophy, a small percentage of ATTR‐CA is known to present with ‘atypical’ cardiac morphologies such as eccentric hypertrophy or even no ...
Takuma Iwaya +6 more
doaj +1 more source
Attred: Attribute Based Resource Discovery for IoT [PDF]
Sensors, 2021 While the number of devices connected together as the Internet of Things (IoT) is growing, the demand for an efficient and secure model of resource discovery in IoT is increasing. An efficient resource discovery model distributes the registration and discovery workload among many nodes and allow the resources to be discovered based on their attributes.
Mohammed Alshawki +3 more
openaire +5 more sources
Diagnosis and Treatment of AL and ATTR Amyloidosis
Journal of the Advanced Practitioner in Oncology, 2021 At JADPRO Live Virtual 2020, Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®, differentiated between AL and ATTR amyloidosis, discussed key considerations in selecting therapy, and identified ways that advanced practitioners can manage the supportive care needs of this patient population.
Faiman, Beth, Richards, Tiffany
openaire +3 more sources
BMC Musculoskeletal Disorders, 2023 Background Hereditary and wild-type transthyretin-mediated (ATTRv and ATTRwt) amyloidoses result from the misfolding of transthyretin and aggregation of amyloid plaques in multiple organ systems.
Emre Aldinc +7 more
doaj +1 more source